UTHR Financial Facts
Operating income: 128.6MTotal revenues: 243.82M
See Full Income Statement
Retained earnings: 553.48M
Property, plant and equipment, net: -823.55M
See Full Balance Sheet
Earnings History for United Therapeutics Corp. (UTHR)
|
Expand Research on UTHR
| Next EPS Date | 2/14/13 | EPS Growth Rate | +58.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +14.2% | Revenue Growth Rate | +19.6% |
| Average % Move 1-Wk after EPS | +6.2% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/13  |
 |
Q113 | $1.24 | $1.47 | -$0.23 | $245.1M | $241.14M | N/A / N/A | = | +5% | Details |
| 2/14/13 | Q412 | N/A | $1.24 | N/A | N/A | $233.41M | N/A / N/A | N/A | N/A | N/A | |
| 2/26/13 |
|
Q412 | $1.65 | $1.25 | +$0.40 | $243.82M | $233.41M | N/A / N/A | = | +15.1% | Details |
| 11/1/12 | Q312 | $1.52 | $1.26 | +$0.26 | $242.5M | $227.63M | $1.26 / $229M | N/A | +45.3% | Details | |
| 7/26/12 |
|
Q212 | $1.34 | $1.12 | +$0.22 | $225.6M | $213.33M | N/A / N/A | N/A | +31.6% | Details |
| 4/26/12 |
|
Q112 | $1.32 | $0.93 | +$0.39 | $204.2M | $203.91M | N/A / N/A | N/A | +53.8% | Details |
| 2/14/12 |
|
Q411 | $0.79 | $0.87 | -$0.08 | $195.2M | $204.81M | N/A / N/A | N/A | +34.7% | Details |
| 10/27/11 |
|
Q311 | $1.65 | $0.73 | +$0.92 | $201.7M | $194.77M | N/A / N/A | N/A | +60% | Details |
